Vollständiger Abstract
Worum geht es in dieser Arbeit?
Abstract Purpose Population-based studies overall report no excess mortality among patients with prolactinoma compared with the general population. However, since prolactinomas are clinically heterogeneous, mortality may not be uniform across data-driven patient profiles. Methods We analyzed 3,378 adult prolactinoma cases (26,118 person-years) from the Surveillance, Epidemiology, and End Results database (2004–2022). Standardized mortality ratios (SMRs) were calculated using US life tables matched by age, sex, calendar year, race/ethnicity, and geography. Among 2,481 patients with available tumor size (18,097 person-years), unsupervised clustering (Fuzzy C-Means) based on age, tumor size, and sex defined patient profiles. Excess mortality ratios (EMRs) compared observed-to-expected mortality across profiles, adjusting for race, calendar year, surgery, and radiotherapy. Results Prolactinoma was associated with significant excess all-cause mortality (SMR 1.21, 95% CI 1.03–1.41). Two profiles emerged: SAYF (Small and Young, Female-predominant; 63%) and LOOM (Large or Old, Male-predominant; 37%). Among patients with tumor size data, mortality was increased in LOOM (SMR 1.36, 95% CI 1.11–1.65) and reduced in SAYF (SMR 0.48, 95% CI 0.22–0.90), with significant between-profile heterogeneity (EMR 2.92, 95% CI 1.44–5.90; p = 0.003). Results were consistent in sensitivity analyses with imputed data, although the survival advantage in SAYF was attenuated and no longer statistically significant. Conclusion Prolactinoma captured in a population-based tumor registry was associated with excess all-cause mortality, with heterogeneity across patient profiles. An older, male-predominant profile with larger tumors showed excess mortality, whereas a younger, female-predominant profile with small tumors showed directionally lower mortality. These hypothesis-generating findings warrant further investigation into the underlying biological and contextual factors.
Bibliografischer Nachweis
Publikationsdaten
- Autor:innen
- Tarik Ziyad Tarik Shwaish, Davide Gori, Claudio Sartori, Federica Guaraldi
- Quelle
- Pituitary
- Publikation
- 2026-01-01
- Band / Ausgabe
- Nicht angegeben
- Seiten
- Nicht angegeben
- ISSN / ISBN
- 1386-341X, 1573-7403
- Zitationen
- 0 laut Crossref
- Referenzen
- 0 hinterlegt
Zitieren
Zitierfähiger Nachweis
Tarik Ziyad Tarik Shwaish, Davide Gori, Claudio Sartori, Federica Guaraldi (2026). Importance of clinical profiling to determine excess mortality in prolactinomas: insights from a large, registry-based cohort. Pituitary. https://doi.org/10.1007/s11102-026-01739-w
Kontext
Themen, Förderung und Nutzung
Lizenzhinweise: Lizenz 1